| 发明名称 |
TRIPLE COMBINATION THERAPY, COMPRISING GANETESPIB, A TAXANE AND AN ANTIBODY, FOR USE IN THE TREATMENT OF HER2 POSITIVE BREAST CANCER |
| 摘要 |
Disclosed herein is a combination therapy comprising ganetespib, a taxane, and a monoclonal antibody that interferes with the HER2/neu receptor, pharmaceutical compositions thereof, and methods for use, such as to treat humans with HER2-positive breast cancer (BC). |
| 申请公布号 |
WO2016094341(A8) |
申请公布日期 |
2016.09.15 |
| 申请号 |
WO2015US64379 |
申请日期 |
2015.12.08 |
| 申请人 |
SYNTA PHARMACEUTICALS CORP. |
发明人 |
PROIA, David |
| 分类号 |
A61K39/395;A61K31/337;A61K31/4196;A61K45/06;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
